GRANISETRON

GRANISETRON was reported 10541 times

GRANISETRON is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LARYNGEAL LEUKOPLAKIA 5 0.2941
1 RESPIRATORY DEPTH DECREASED 7 0.1014
2 ULTRASOUND FOETAL ABNORMAL 8 0.0952
3 SUBCLAVIAN ARTERY OCCLUSION 6 0.0594
4 ANTITHROMBIN III DECREASED 16 0.0586
5 BONE ATROPHY 8 0.0471
6 DYSAESTHESIA PHARYNX 8 0.0457
7 GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOUR DISEASE 5 0.0450
8 RESTRICTIVE CARDIOMYOPATHY 11 0.0363
9 RADIATION OESOPHAGITIS 12 0.0315
10 CHRONIC HEPATITIS B 9 0.0284
11 INSULIN AUTOIMMUNE SYNDROME 10 0.0280
12 APPLICATION SITE MASS 7 0.0255
13 SYSTEMIC INFECTION 39 0.0235
14 TUMOUR PERFORATION 7 0.0220
15 ANAEMIA OF MALIGNANT DISEASE 6 0.0214
16 URINARY TRACT INFECTION PSEUDOMONAL 12 0.0200
17 NAIL BED INFLAMMATION 6 0.0188
18 ACUTE INTERSTITIAL PNEUMONITIS 9 0.0172
19 PSEUDOMONAL BACTERAEMIA 14 0.0164
20 AORTITIS 11 0.0160
21 METASTASES TO BONE MARROW 8 0.0160
22 CELLULITE 5 0.0153
23 PHARYNGEAL INFLAMMATION 18 0.0148
24 AUTOIMMUNE COLITIS 9 0.0140
25 ENGRAFTMENT SYNDROME 8 0.0135
26 ILEAL PERFORATION 8 0.0121
27 ONYCHALGIA 12 0.0120
28 GLUCOCORTICOID DEFICIENCY 5 0.0118
29 MALIGNANT ASCITES 9 0.0117
30 ALLERGY TO CHEMICALS 14 0.0112
31 FEBRILE NEUTROPENIA 743 0.0112
32 PRODUCT ADHESION ISSUE 399 0.0112
33 NEUTROPENIC COLITIS 23 0.0111
34 OESOPHAGEAL HAEMORRHAGE 14 0.0106
35 NEUTROPENIC INFECTION 10 0.0104
36 IMMUNE-MEDIATED THYROIDITIS 5 0.0101
37 HEART TRANSPLANT 9 0.0099
38 FLUID IMBALANCE 7 0.0099
39 HEPATOBILIARY DISEASE 6 0.0096
40 PULPITIS DENTAL 9 0.0095
41 OSTEOCHONDROSIS 11 0.0095
42 MUCOSAL DISORDER 9 0.0091
43 POST PROCEDURAL SEPSIS 6 0.0090
44 CARTILAGE ATROPHY 7 0.0087
45 HEPATIC INFECTION 11 0.0086
46 BLAST CELL COUNT INCREASED 9 0.0086
47 FEBRILE INFECTION 10 0.0085
48 DRUG CLEARANCE DECREASED 11 0.0084
49 ORTHOSTATIC INTOLERANCE 6 0.0084
50 TOOTH EROSION 10 0.0082
51 THROMBOTIC STROKE 6 0.0082
52 SKIN OEDEMA 8 0.0080
53 VENOUS THROMBOSIS LIMB 16 0.0077
54 ENTEROCOLITIS INFECTIOUS 7 0.0076
55 PULMONARY SEPSIS 11 0.0076
56 JUGULAR VEIN THROMBOSIS 13 0.0073
57 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 24 0.0072
58 VENOOCCLUSIVE DISEASE 18 0.0072
59 RADIATION SKIN INJURY 8 0.0069
60 SUBILEUS 14 0.0067
61 PROTEIN URINE 6 0.0066
62 MUCOUS MEMBRANE DISORDER 9 0.0066
63 INCISIONAL HERNIA 9 0.0065
64 INJECTION SITE CELLULITIS 12 0.0065
65 PERIPHERAL MOTOR NEUROPATHY 9 0.0064
66 APLASTIC ANAEMIA 33 0.0063
67 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 7 0.0063
68 FOLATE DEFICIENCY 7 0.0061
69 VENA CAVA THROMBOSIS 10 0.0060
70 PERIODONTITIS 13 0.0060
71 DERMATITIS ACNEIFORM 36 0.0059
72 POLYNEUROPATHY 70 0.0058
73 LYMPHANGIOSIS CARCINOMATOSA 6 0.0058
74 MUCOSAL INFLAMMATION 150 0.0057
75 MITRAL VALVE DISEASE 10 0.0056
76 PERIPHERAL SENSORY NEUROPATHY 33 0.0056
77 HYPERAEMIA 11 0.0056
78 NEUTROPHIL COUNT DECREASED 227 0.0056
79 ILEUS 69 0.0055
80 NEUTROPENIC SEPSIS 39 0.0055
81 PNEUMONIA KLEBSIELLA 10 0.0054
82 IMMUNE-MEDIATED ENTEROCOLITIS 20 0.0054
83 ENTEROCOLITIS 31 0.0054
84 HYPOPROTEINAEMIA 10 0.0053
85 INTESTINAL DILATATION 7 0.0052
86 CACHEXIA 27 0.0052
87 CYSTITIS HAEMORRHAGIC 21 0.0052
88 OESOPHAGITIS 56 0.0051
89 DEVICE RELATED THROMBOSIS 5 0.0051
90 STREPTOCOCCAL SEPSIS 6 0.0051
91 STAPHYLOCOCCAL BACTERAEMIA 22 0.0051
92 LEUKOPENIA 252 0.0050
93 DRUG ADMINISTERED AT INAPPROPRIATE SITE 53 0.0050
94 ADMINISTRATION SITE EXTRAVASATION 5 0.0050
95 CAPILLARY LEAK SYNDROME 10 0.0048
96 DISSEMINATED INTRAVASCULAR COAGULATION 68 0.0048
97 RESUSCITATION 8 0.0048
98 GASTRIC DILATATION 8 0.0048
99 IRON OVERLOAD 5 0.0046
100 HYPOALBUMINAEMIA 36 0.0046
101 MYELITIS 7 0.0045
102 LARYNGOSPASM 12 0.0045
103 IMMUNE-MEDIATED HYPOTHYROIDISM 5 0.0044
104 IMMUNE-MEDIATED HEPATITIS 9 0.0044
105 IMPAIRED SELF-CARE 9 0.0043
106 WOUND HAEMORRHAGE 16 0.0043
107 PARONYCHIA 19 0.0043
108 PRERENAL FAILURE 6 0.0043
109 INTENSIVE CARE 6 0.0042
110 PELVIC VENOUS THROMBOSIS 6 0.0042
111 SPUTUM INCREASED 9 0.0042
112 COLITIS ISCHAEMIC 28 0.0041
113 GASTROINTESTINAL NECROSIS 12 0.0041
114 NON-CARDIAC CHEST PAIN 13 0.0041
115 APLASIA 8 0.0041
116 WOUND SECRETION 16 0.0041
117 STAPHYLOCOCCAL SEPSIS 20 0.0040
118 LARGE INTESTINE PERFORATION 28 0.0040
119 LEFT VENTRICULAR DYSFUNCTION 27 0.0040
120 HICCUPS 33 0.0040
121 APPLICATION SITE WARMTH 5 0.0039
122 STOMA SITE HAEMORRHAGE 6 0.0039
123 APPLICATION SITE RASH 53 0.0039
124 IMMUNE-MEDIATED LUNG DISEASE 7 0.0038
125 BONE MARROW FAILURE 78 0.0038
126 UROSEPSIS 35 0.0038
127 GASTROENTERITIS NOROVIRUS 5 0.0038
128 PNEUMONITIS 102 0.0037
129 THROMBOTIC THROMBOCYTOPENIC PURPURA 13 0.0037
130 PULMONARY TOXICITY 26 0.0037
131 NEUTROPENIA 494 0.0036
132 GASTROINTESTINAL PERFORATION 15 0.0036
133 TACHYPNOEA 49 0.0036
134 PNEUMOCYSTIS JIROVECI PNEUMONIA 8 0.0036
135 PSEUDOMEMBRANOUS COLITIS 8 0.0036
136 METASTASES TO PERITONEUM 9 0.0036
137 SKIN TOXICITY 20 0.0035
138 HYPOKALAEMIA 163 0.0035
139 BACTERAEMIA 41 0.0035
140 ESCHERICHIA SEPSIS 10 0.0034
141 ACUTE ABDOMEN 5 0.0034
142 VULVOVAGINAL DRYNESS 11 0.0034
143 COLORECTAL CANCER METASTATIC 8 0.0034
144 HYPERTHERMIA MALIGNANT 5 0.0034
145 HYPOVOLAEMIC SHOCK 16 0.0033
146 LUNG ABSCESS 7 0.0033
147 SEROTONIN SYNDROME 64 0.0033
148 LYMPHOEDEMA 23 0.0033
149 TETANY 6 0.0033
150 ENTERITIS 21 0.0033
151 SOFT TISSUE INFECTION 6 0.0033
152 SINUS NODE DYSFUNCTION 6 0.0033
153 ORAL CANDIDIASIS 43 0.0033
154 DYSAESTHESIA 10 0.0033
155 HYPERPHOSPHATAEMIA 7 0.0033
156 ELECTROCARDIOGRAM T WAVE ABNORMAL 5 0.0032
157 MEGACOLON 5 0.0032
158 RESPIRATORY SYMPTOM 9 0.0032
159 BLOOD LACTATE DEHYDROGENASE INCREASED 49 0.0031
160 CYTOKINE RELEASE SYNDROME 62 0.0031
161 GENERAL PHYSICAL HEALTH DETERIORATION 356 0.0031
162 HYPOGEUSIA 6 0.0031
163 STRIDOR 9 0.0031
164 PANCYTOPENIA 170 0.0030
165 OTITIS MEDIA 10 0.0030
166 THROMBOCYTOPENIA 336 0.0030
167 PROSTATE CANCER METASTATIC 10 0.0030
168 HYPOMANIA 11 0.0030
169 AMYLASE INCREASED 11 0.0030
170 ESCHERICHIA BACTERAEMIA 7 0.0030
171 METASTASES TO SPINE 10 0.0030
172 PLATELET COUNT DECREASED 317 0.0030
173 GASTRIC PERFORATION 8 0.0029
174 CIRCULATORY COLLAPSE 50 0.0029
175 STOMATITIS 176 0.0029
176 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 8 0.0029
177 TUMOUR LYSIS SYNDROME 25 0.0028
178 IMMUNE THROMBOCYTOPENIC PURPURA 8 0.0028
179 METASTASES TO LIVER 49 0.0028
180 PERFORMANCE STATUS DECREASED 13 0.0028
181 APPLICATION SITE PRURITUS 63 0.0028
182 EMBOLISM 23 0.0028
183 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 64 0.0027
184 HYPERTRIGLYCERIDAEMIA 16 0.0027
185 NON-SMALL CELL LUNG CANCER 13 0.0027
186 APPLICATION SITE DISCOLOURATION 11 0.0027
187 GUILLAIN-BARRE SYNDROME 13 0.0027
188 ADENOCARCINOMA 6 0.0027
189 PROTHROMBIN TIME PROLONGED 16 0.0027
190 INTESTINAL PERFORATION 30 0.0027
191 HYDRONEPHROSIS 20 0.0027
192 WOUND DEHISCENCE 9 0.0027
193 LYMPHOCYTE COUNT DECREASED 47 0.0027
194 DRUG PRESCRIBING ERROR 51 0.0027
195 METASTASES TO CENTRAL NERVOUS SYSTEM 34 0.0026
196 BREAST CANCER METASTATIC 28 0.0026
197 BLOOD URIC ACID INCREASED 15 0.0026
198 BRADYPNOEA 7 0.0026
199 ANAEMIA 493 0.0026
200 SINUS TACHYCARDIA 36 0.0025
201 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 15 0.0025
202 URINARY TRACT OBSTRUCTION 6 0.0025
203 METASTASES TO LYMPH NODES 17 0.0025
204 WHITE BLOOD CELL COUNT DECREASED 273 0.0025
205 ARTERIOSPASM CORONARY 10 0.0025
206 SEPTIC SHOCK 108 0.0025
207 PULMONARY HAEMORRHAGE 19 0.0024
208 AORTIC DISSECTION 10 0.0024
209 APPLICATION SITE IRRITATION 30 0.0024
210 PROTEIN TOTAL DECREASED 9 0.0024
211 SINUS BRADYCARDIA 23 0.0024
212 APPENDICITIS PERFORATED 6 0.0024
213 SEPSIS 263 0.0024
214 HEPATIC FAILURE 71 0.0024
215 FEBRILE BONE MARROW APLASIA 10 0.0024
216 FLANK PAIN 22 0.0023
217 CARBOHYDRATE ANTIGEN 125 INCREASED 8 0.0023
218 HAEMOLYTIC ANAEMIA 21 0.0023
219 METASTASES TO LUNG 27 0.0023
220 CATHETER SITE PAIN 6 0.0023
221 HYPOPHOSPHATAEMIA 17 0.0023
222 VENOUS THROMBOSIS 9 0.0023
223 INTERSTITIAL LUNG DISEASE 111 0.0023
224 APPLICATION SITE ERYTHEMA 60 0.0023
225 HYPOCALCAEMIA 43 0.0023
226 PNEUMOTHORAX 36 0.0023
227 GRAFT VERSUS HOST DISEASE IN SKIN 5 0.0023
228 JAUNDICE CHOLESTATIC 8 0.0023
229 CLOSTRIDIUM DIFFICILE COLITIS 24 0.0023
230 PERSONALITY CHANGE 21 0.0023
231 NEUTROPHIL COUNT INCREASED 23 0.0022
232 BLEPHARITIS 9 0.0022
233 ILEUS PARALYTIC 10 0.0022
234 HEPATOMEGALY 22 0.0022
235 SENSORY LOSS 18 0.0022
236 ANAL ABSCESS 12 0.0022
237 HYPERNATRAEMIA 11 0.0022
238 VASCULAR DEVICE INFECTION 10 0.0022
239 KOUNIS SYNDROME 5 0.0022
240 HYPERAMMONAEMIA 11 0.0022
241 TRANSFUSION 23 0.0022
242 BRONCHOPULMONARY ASPERGILLOSIS 17 0.0022
243 TYPE IV HYPERSENSITIVITY REACTION 6 0.0022
244 HYPERURICAEMIA 9 0.0022
245 ANAPHYLACTOID REACTION 9 0.0022
246 PATHOLOGICAL FRACTURE 11 0.0022
247 PORTAL VEIN THROMBOSIS 7 0.0022
248 HYPERTENSIVE CRISIS 24 0.0022
249 PROTEINURIA 41 0.0022
250 HYPOMAGNESAEMIA 30 0.0022
251 RENAL TUBULAR DISORDER 6 0.0021
252 HYPERBILIRUBINAEMIA 22 0.0021
253 CYTOPENIA 26 0.0021
254 GAMMA-GLUTAMYLTRANSFERASE INCREASED 47 0.0021
255 TASTE DISORDER 43 0.0021
256 ACUTE LYMPHOCYTIC LEUKAEMIA 6 0.0021
257 TUMOUR HAEMORRHAGE 6 0.0021
258 CYANOSIS 33 0.0021
259 CHOLANGITIS 13 0.0021
260 BLOOD UREA INCREASED 35 0.0021
261 BLOOD BILIRUBIN INCREASED 56 0.0021
262 LUMBAR SPINAL STENOSIS 6 0.0021
263 INFUSION RELATED REACTION 135 0.0020
264 HEPATIC FUNCTION ABNORMAL 76 0.0020
265 APPLICATION SITE BURN 10 0.0020
266 CARDIOMYOPATHY 30 0.0020
267 PLEURAL EFFUSION 123 0.0020
268 MICTURITION DISORDER 7 0.0020
269 AZOTAEMIA 8 0.0020
270 EJECTION FRACTION DECREASED 31 0.0020
271 ERYSIPELAS 10 0.0020
272 HAEMATEMESIS 50 0.0020
273 PROSTATITIS 6 0.0020
274 ATELECTASIS 19 0.0020
275 ACUTE GRAFT VERSUS HOST DISEASE 9 0.0020
276 METASTASIS 14 0.0020
277 PERIPHERAL ISCHAEMIA 8 0.0020
278 ABDOMINAL INFECTION 5 0.0020
279 CANCER PAIN 5 0.0020
280 C-REACTIVE PROTEIN INCREASED 71 0.0019
281 METASTASES TO BONE 32 0.0019
282 DEVICE RELATED INFECTION 30 0.0019
283 MEAN CELL VOLUME INCREASED 5 0.0019
284 HAEMOLYSIS 15 0.0019
285 TRISMUS 10 0.0019
286 PERIORBITAL OEDEMA 10 0.0019
287 HOSPICE CARE 19 0.0019
288 HYPERGLYCAEMIA 70 0.0019
289 PYREXIA 664 0.0019
290 BLOOD PHOSPHORUS DECREASED 7 0.0019
291 ASPARTATE AMINOTRANSFERASE INCREASED 101 0.0019
292 TACHYCARDIA 168 0.0019
293 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 18 0.0019
294 SUPRAVENTRICULAR TACHYCARDIA 18 0.0019
295 ATRIAL FLUTTER 15 0.0019
296 ASCITES 55 0.0019
297 RED BLOOD CELL COUNT DECREASED 53 0.0019
298 BLOOD SODIUM INCREASED 5 0.0019
299 PSYCHOLOGICAL TRAUMA 16 0.0019
300 CONSTIPATION 404 0.0019
301 GASTROENTERITIS 27 0.0018
302 HYPOXIA 65 0.0018
303 BACTERIAL SEPSIS 6 0.0018
304 OEDEMA MOUTH 6 0.0018
305 TONGUE OEDEMA 7 0.0018
306 ALANINE AMINOTRANSFERASE INCREASED 112 0.0018
307 ANAPHYLACTIC REACTION 100 0.0018
308 EOSINOPHIL COUNT INCREASED 15 0.0018
309 CYTOMEGALOVIRUS VIRAEMIA 8 0.0018
310 NEPHRITIS 6 0.0018
311 ACUTE MYELOID LEUKAEMIA 28 0.0018
312 ANAL HAEMORRHAGE 5 0.0018
313 RASH PUSTULAR 13 0.0018
314 CANDIDA INFECTION 30 0.0018
315 PNEUMONIA FUNGAL 7 0.0018
316 CHOLECYSTITIS ACUTE 10 0.0018
317 BLOOD ALBUMIN DECREASED 14 0.0018
318 OESOPHAGEAL CANDIDIASIS 7 0.0018
319 NEOPLASM PROGRESSION 61 0.0018
320 BRONCHOPNEUMONIA 6 0.0018
321 AUTOIMMUNE HAEMOLYTIC ANAEMIA 6 0.0017
322 ANAPHYLACTIC SHOCK 45 0.0017
323 MALIGNANT NEOPLASM PROGRESSION 178 0.0017
324 BLOOD PRESSURE DIASTOLIC INCREASED 8 0.0017
325 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 122 0.0017
326 COLITIS 65 0.0017
327 HYPOVOLAEMIA 10 0.0017
328 SERUM FERRITIN INCREASED 9 0.0017
329 EXTRAVASATION 7 0.0017
330 NAUSEA 1346 0.0017
331 PANCREATITIS ACUTE 38 0.0017
332 DIFFUSE LARGE B-CELL LYMPHOMA 13 0.0017
333 HISTIOCYTOSIS HAEMATOPHAGIC 5 0.0017
334 HAEMATOTOXICITY 16 0.0017
335 CARDIAC TAMPONADE 8 0.0017
336 CARDIOTOXICITY 15 0.0017
337 ATYPICAL PNEUMONIA 5 0.0017
338 LUNG ADENOCARCINOMA 5 0.0017
339 NEUROTOXICITY 29 0.0017
340 MONOCYTE COUNT INCREASED 6 0.0017
341 CARDIAC FAILURE ACUTE 11 0.0016
342 NEUROPATHY PERIPHERAL 157 0.0016
343 VOMITING 776 0.0016
344 ESCHERICHIA URINARY TRACT INFECTION 7 0.0016
345 DEHYDRATION 219 0.0016
346 DECREASED APPETITE 381 0.0016
347 THROMBOCYTOSIS 6 0.0016
348 MOUTH HAEMORRHAGE 12 0.0016
349 GASTRIC ULCER HAEMORRHAGE 9 0.0016
350 BREATH SOUNDS ABNORMAL 8 0.0016
351 HYPONATRAEMIA 91 0.0016
352 ERYTHEMA MULTIFORME 15 0.0016
353 HYPOPHAGIA 41 0.0016
354 HYPOTONIA 16 0.0016
355 DERMATITIS EXFOLIATIVE 8 0.0016
356 CHEMOTHERAPY 6 0.0016
357 HYPERAESTHESIA 13 0.0016
358 PURPURA 14 0.0016
359 TOXIC ENCEPHALOPATHY 8 0.0016
360 HAEMODYNAMIC INSTABILITY 12 0.0016
361 BLOOD ALKALINE PHOSPHATASE INCREASED 39 0.0016
362 ACIDOSIS 12 0.0016
363 RESPIRATORY FAILURE 114 0.0016
364 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 16 0.0016
365 CEREBRAL ISCHAEMIA 8 0.0016
366 UPPER GASTROINTESTINAL HAEMORRHAGE 26 0.0015
367 SMALL INTESTINAL OBSTRUCTION 19 0.0015
368 VENTRICULAR EXTRASYSTOLES 16 0.0015
369 COLD SWEAT 27 0.0015
370 GRAFT VERSUS HOST DISEASE 11 0.0015
371 MALNUTRITION 17 0.0015
372 TOXIC EPIDERMAL NECROLYSIS 23 0.0015
373 SKIN REACTION 21 0.0015
374 DERMATITIS CONTACT 17 0.0015
375 TOXIC SKIN ERUPTION 15 0.0015
376 APPLICATION SITE DRYNESS 5 0.0015
377 PULSE ABSENT 7 0.0015
378 PERICARDIAL EFFUSION 34 0.0015
379 ACUTE HEPATIC FAILURE 20 0.0015
380 SUBCUTANEOUS ABSCESS 7 0.0015
381 HYPERCALCAEMIA 18 0.0015
382 OLIGURIA 9 0.0014
383 PERITONITIS 30 0.0014
384 RED CELL DISTRIBUTION WIDTH INCREASED 6 0.0014
385 THROAT TIGHTNESS 39 0.0014
386 OEDEMA 78 0.0014
387 THROMBOTIC MICROANGIOPATHY 14 0.0014
388 SENSATION OF FOREIGN BODY 12 0.0014
389 INCONTINENCE 15 0.0014
390 VENOOCCLUSIVE LIVER DISEASE 7 0.0014
391 FACIAL PARESIS 5 0.0014
392 BLOOD CREATININE INCREASED 92 0.0014
393 APPLICATION SITE VESICLES 9 0.0014
394 LEUKOCYTOSIS 25 0.0014
395 BLOOD SODIUM DECREASED 26 0.0014
396 STRESS CARDIOMYOPATHY 8 0.0014
397 HAEMOGLOBIN DECREASED 141 0.0014
398 DISEASE PROGRESSION 162 0.0014
399 OXYGEN SATURATION DECREASED 76 0.0014
400 AGRANULOCYTOSIS 25 0.0013
401 LEUKOENCEPHALOPATHY 5 0.0013
402 RESPIRATORY DISTRESS 37 0.0013
403 NYSTAGMUS 7 0.0013
404 ADRENAL INSUFFICIENCY 16 0.0013
405 IMMUNE THROMBOCYTOPENIA 6 0.0013
406 ISCHAEMIA 6 0.0013
407 MENTAL STATUS CHANGES 36 0.0013
408 ELECTROLYTE IMBALANCE 15 0.0013
409 PHARYNGITIS 16 0.0013
410 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 10 0.0013
411 BACTERIAL INFECTION 24 0.0013
412 HYDROCEPHALUS 7 0.0013
413 FAECALOMA 7 0.0013
414 MULTI-ORGAN FAILURE 22 0.0013
415 SKIN ABRASION 6 0.0013
416 HYPOTENSION 254 0.0013
417 HEPATOTOXICITY 28 0.0013
418 ABDOMINAL PAIN 292 0.0013
419 PULMONARY ALVEOLAR HAEMORRHAGE 7 0.0012
420 MYDRIASIS 16 0.0012
421 LUNG INFILTRATION 11 0.0012
422 ACUTE RESPIRATORY DISTRESS SYNDROME 22 0.0012
423 ENTEROCOCCAL INFECTION 6 0.0012
424 RHINITIS 10 0.0012
425 FACIAL PAIN 11 0.0012
426 PERONEAL NERVE PALSY 7 0.0012
427 PULMONARY EMBOLISM 117 0.0012
428 GENERALISED ERYTHEMA 7 0.0012
429 HEPATITIS ACUTE 8 0.0012
430 SUDDEN DEATH 13 0.0012
431 MYOSITIS 11 0.0012
432 ESCHERICHIA INFECTION 10 0.0012
433 HAIR DISORDER 10 0.0012
434 INFLAMMATORY MARKER INCREASED 6 0.0012
435 SMALL FOR DATES BABY 6 0.0012
436 ABDOMINAL TENDERNESS 6 0.0012
437 BONE DISORDER 22 0.0012
438 HAIR COLOUR CHANGES 15 0.0012
439 FLUID INTAKE REDUCED 6 0.0012
440 PNEUMONIA BACTERIAL 11 0.0012
441 JAUNDICE 32 0.0012
442 ACUTE MYOCARDIAL INFARCTION 35 0.0012
443 ACUTE KIDNEY INJURY 181 0.0012
444 STAPHYLOCOCCAL INFECTION 39 0.0012
445 ATAXIA 14 0.0012
446 PALLOR 32 0.0012
447 LIPASE INCREASED 9 0.0012
448 MYOCLONUS 14 0.0012
449 PHLEBITIS 6 0.0012
450 TRANSAMINASES INCREASED 26 0.0012
451 NEPHROTIC SYNDROME 8 0.0012
452 PNEUMONIA 377 0.0012
453 TYPE 1 DIABETES MELLITUS 7 0.0012
454 CHILLS 136 0.0012
455 SKIN INFECTION 13 0.0012
456 LUNG INFECTION 18 0.0012
457 HEPATIC LESION 5 0.0012
458 PRESYNCOPE 28 0.0012
459 FLUSHING 117 0.0011
460 AUTOIMMUNE HEPATITIS 8 0.0011
461 MITRAL VALVE INCOMPETENCE 13 0.0011
462 WEIGHT FLUCTUATION 12 0.0011
463 DIVERTICULUM INTESTINAL 5 0.0011
464 APPLICATION SITE REACTION 8 0.0011
465 EPISTAXIS 85 0.0011
466 ABDOMINAL ABSCESS 5 0.0011
467 DIARRHOEA 729 0.0011
468 CARDIOGENIC SHOCK 16 0.0011
469 GINGIVITIS 6 0.0011
470 PARAESTHESIA ORAL 16 0.0011
471 MYELODYSPLASTIC SYNDROME 16 0.0011
472 TONGUE DISORDER 8 0.0011
473 ENCEPHALOPATHY 27 0.0011
474 BLOOD PRESSURE SYSTOLIC DECREASED 5 0.0011
475 CYSTITIS 35 0.0011
476 ASPIRATION 12 0.0011
477 MULTIPLE ORGAN DYSFUNCTION SYNDROME 31 0.0011
478 LUMBAR VERTEBRAL FRACTURE 5 0.0011
479 INTESTINAL ISCHAEMIA 6 0.0011
480 PROCTALGIA 7 0.0011
481 ACUTE CORONARY SYNDROME 9 0.0011
482 DRUG-INDUCED LIVER INJURY 34 0.0011
483 HYPERKALAEMIA 38 0.0011
484 SKIN ULCER 28 0.0011
485 MYELOSUPPRESSION 39 0.0011
486 HAEMATURIA 37 0.0011
487 HERPES SIMPLEX 7 0.0011
488 ORAL PAIN 24 0.0011
489 ANGIOPATHY 6 0.0011
490 DYSPNOEA 606 0.0011
491 NEPHROPATHY TOXIC 12 0.0011
492 HAEMATOCHEZIA 59 0.0011
493 ABDOMINAL PAIN LOWER 27 0.0011
494 ALTERED STATE OF CONSCIOUSNESS 23 0.0011
495 LIVER DISORDER 47 0.0011
496 CHEST DISCOMFORT 108 0.0011
497 PETECHIAE 11 0.0011
498 GRANULOCYTOPENIA 6 0.0011
499 BRONCHOSPASM 15 0.0011
500 LIP SWELLING 35 0.0010
501 DYSGEUSIA 78 0.0010
502 NEUROLOGICAL SYMPTOM 6 0.0010
503 HYPERTHERMIA 8 0.0010
504 PNEUMONIA ASPIRATION 26 0.0010
505 HAEMOPTYSIS 29 0.0010
506 PYELONEPHRITIS 9 0.0010
507 HYPERTHYROIDISM 15 0.0010
508 ATRIOVENTRICULAR BLOCK 8 0.0010
509 RASH MACULO-PAPULAR 23 0.0010
510 HYPOKINESIA 15 0.0010
511 GENERAL PHYSICAL CONDITION ABNORMAL 7 0.0010
512 SKIN WARM 6 0.0010
513 URINE OUTPUT DECREASED 9 0.0010
514 SPLENOMEGALY 12 0.0010
515 ELECTROCARDIOGRAM ABNORMAL 8 0.0010
516 AFFECTIVE DISORDER 8 0.0010
517 BRADYKINESIA 6 0.0010
518 PLEURISY 6 0.0010
519 BLOOD PRESSURE DECREASED 67 0.0010
520 PULMONARY HYPERTENSION 21 0.0010
521 OEDEMA PERIPHERAL 122 0.0010
522 ELECTROCARDIOGRAM QT PROLONGED 36 0.0010
523 BLOOD DISORDER 8 0.0010
524 CARDIAC FAILURE 80 0.0010
525 FULL BLOOD COUNT DECREASED 20 0.0010
526 DUODENAL ULCER 7 0.0010
527 VENTRICULAR FIBRILLATION 11 0.0010
528 LYMPHOPENIA 14 0.0010
529 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 6 0.0010
530 PRODUCTIVE COUGH 47 0.0010
531 CEREBRAL INFARCTION 24 0.0010
532 SYNCOPE 98 0.0010
533 FISTULA 11 0.0010
534 ATRIAL FIBRILLATION 95 0.0010
535 ENDOCARDITIS 5 0.0010
536 BONE PAIN 57 0.0010
537 PIGMENTATION DISORDER 6 0.0010
538 UNRESPONSIVE TO STIMULI 25 0.0010
539 WHITE BLOOD CELL COUNT INCREASED 37 0.0010
540 FAILURE TO THRIVE 5 0.0010
541 CLOSTRIDIUM DIFFICILE INFECTION 21 0.0010
542 THERAPY PARTIAL RESPONDER 15 0.0010
543 HAEMATOCRIT DECREASED 19 0.0010
544 DERMATITIS ALLERGIC 12 0.0010
545 MADAROSIS 11 0.0009
546 FEELING HOT 58 0.0009
547 HEMIPARESIS 16 0.0009
548 DYSPHONIA 55 0.0009
549 FEEDING DISORDER 19 0.0009
550 ACUTE RESPIRATORY FAILURE 18 0.0009
551 SENSORY DISTURBANCE 15 0.0009
552 PSEUDOMONAS INFECTION 8 0.0009
553 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 7 0.0009
554 BODY TEMPERATURE INCREASED 19 0.0009
555 DYSPNOEA EXERTIONAL 35 0.0009
556 URINARY RETENTION 31 0.0009
557 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 17 0.0009
558 BLOOD MAGNESIUM DECREASED 8 0.0009
559 RESPIRATORY TRACT INFECTION 24 0.0009
560 RENAL FAILURE ACUTE 39 0.0009
561 REFUSAL OF TREATMENT BY PATIENT 6 0.0009
562 PAIN IN JAW 26 0.0009
563 HYPOGAMMAGLOBULINAEMIA 6 0.0009
564 HEPATIC STEATOSIS 17 0.0009
565 TERMINAL STATE 6 0.0009
566 HAIR TEXTURE ABNORMAL 12 0.0009
567 BLOOD CALCIUM DECREASED 10 0.0009
568 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 179 0.0009
569 HYPOTHYROIDISM 28 0.0009
570 ECCHYMOSIS 6 0.0009
571 HYPERTONIA 5 0.0009
572 HAEMORRHOIDS 17 0.0009
573 BRAIN NEOPLASM 8 0.0009
574 HERPES VIRUS INFECTION 5 0.0009
575 URINARY TRACT INFECTION 148 0.0009
576 ENCEPHALITIS 6 0.0009
577 DYSPHAGIA 82 0.0009
578 NEURALGIA 21 0.0009
579 MELAENA 19 0.0009
580 DEEP VEIN THROMBOSIS 56 0.0009
581 GASTROINTESTINAL HAEMORRHAGE 72 0.0009
582 DEPRESSED LEVEL OF CONSCIOUSNESS 34 0.0009
583 MASS 12 0.0009
584 BLOOD COUNT ABNORMAL 13 0.0009
585 POLYURIA 7 0.0009
586 HAEMATOMA 22 0.0008
587 DRUG ERUPTION 15 0.0008
588 METABOLIC ACIDOSIS 27 0.0008
589 INFECTION 122 0.0008
590 CYTOMEGALOVIRUS INFECTION 14 0.0008
591 GASTRIC ULCER 16 0.0008
592 MUSCULOSKELETAL CHEST PAIN 13 0.0008
593 HYPERHIDROSIS 108 0.0008
594 CELLULITIS 42 0.0008
595 DIABETIC KETOACIDOSIS 20 0.0008
596 BRADYCARDIA 44 0.0008
597 SKIN LACERATION 9 0.0008
598 ERYTHEMA 170 0.0008
599 PARAESTHESIA 130 0.0008
600 WOUND 23 0.0008
601 APPLICATION SITE PAIN 18 0.0008
602 BLINDNESS TRANSIENT 6 0.0008
603 OSTEONECROSIS OF JAW 20 0.0008
604 GENERALISED OEDEMA 10 0.0008
605 IMPAIRED GASTRIC EMPTYING 11 0.0008
606 RENAL FAILURE 107 0.0008
607 NAIL DISORDER 7 0.0008
608 THROMBOSIS 64 0.0008
609 TROPONIN INCREASED 6 0.0008
610 PHOTOSENSITIVITY REACTION 13 0.0008
611 ALOPECIA 154 0.0008
612 DEVICE OCCLUSION 11 0.0008
613 GASTROINTESTINAL INFECTION 7 0.0008
614 LABORATORY TEST ABNORMAL 23 0.0008
615 UPPER RESPIRATORY TRACT INFECTION 36 0.0008
616 HEPATOCELLULAR INJURY 11 0.0008
617 CARDIAC ARREST 64 0.0008
618 RASH PRURITIC 42 0.0008
619 EYELID OEDEMA 9 0.0008
620 RASH ERYTHEMATOUS 37 0.0008
621 INTERNATIONAL NORMALISED RATIO INCREASED 22 0.0008
622 PELVIC PAIN 14 0.0008
623 SPINAL PAIN 9 0.0008
624 BACK PAIN 178 0.0008
625 ASTHENIA 288 0.0008
626 DERMATITIS 16 0.0008
627 COUGH 214 0.0008
628 COVID-19 PNEUMONIA 9 0.0008
629 GASTRITIS 20 0.0008
630 MOUTH ULCERATION 16 0.0008
631 FURUNCLE 6 0.0008
632 TRICUSPID VALVE INCOMPETENCE 6 0.0008
633 RETCHING 16 0.0007
634 HEPATIC ENCEPHALOPATHY 7 0.0007
635 DIARRHOEA HAEMORRHAGIC 7 0.0007
636 HYPERSENSITIVITY 139 0.0007
637 PLASMA CELL MYELOMA 29 0.0007
638 SPUTUM DISCOLOURED 7 0.0007
639 RENAL IMPAIRMENT 62 0.0007
640 PULMONARY OEDEMA 33 0.0007
641 MUSCULOSKELETAL DISORDER 14 0.0007
642 FATIGUE 572 0.0007
643 CARDIOMEGALY 9 0.0007
644 BLOOD POTASSIUM DECREASED 22 0.0007
645 CHEST PAIN 135 0.0007
646 MUSCULOSKELETAL PAIN 38 0.0007
647 DRUG LEVEL INCREASED 12 0.0007
648 DIZZINESS POSTURAL 7 0.0007
649 DELIRIUM 25 0.0007
650 COAGULOPATHY 12 0.0007
651 RENAL TUBULAR NECROSIS 7 0.0007
652 WEIGHT DECREASED 199 0.0007
653 DRUG INTERACTION 113 0.0007
654 FACE OEDEMA 12 0.0007
655 SKIN PLAQUE 6 0.0007
656 DEATH 611 0.0007
657 STATUS EPILEPTICUS 8 0.0007
658 DYSURIA 26 0.0007
659 BLADDER DISORDER 7 0.0007
660 MYOCARDIAL ISCHAEMIA 8 0.0007
661 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 5 0.0007
662 PNEUMOCYSTIS JIROVECII PNEUMONIA 7 0.0007
663 NEOPLASM 8 0.0007
664 BLOOD CREATINE PHOSPHOKINASE INCREASED 20 0.0007
665 HYPERTENSION 147 0.0007
666 FAECES DISCOLOURED 15 0.0007
667 ABDOMINAL DISTENSION 72 0.0007
668 VERTIGO 42 0.0007
669 RESPIRATORY SYNCYTIAL VIRUS INFECTION 6 0.0007
670 FAECES SOFT 5 0.0007
671 SUBARACHNOID HAEMORRHAGE 7 0.0007
672 DIVERTICULITIS 19 0.0007
673 RESTLESSNESS 25 0.0007
674 ARRHYTHMIA 32 0.0007
675 COLON CANCER 10 0.0007
676 CEREBRAL HAEMORRHAGE 24 0.0007
677 PRODUCT USE IN UNAPPROVED INDICATION 166 0.0007
678 HAEMORRHAGE INTRACRANIAL 10 0.0007
679 FOLLICULITIS 7 0.0007
680 GENERALISED TONIC-CLONIC SEIZURE 11 0.0007
681 DYSARTHRIA 25 0.0007
682 ANGINA PECTORIS 19 0.0007
683 RASH 289 0.0007
684 APHASIA 20 0.0007
685 FUNGAL INFECTION 22 0.0007
686 RESTLESS LEGS SYNDROME 12 0.0007
687 GINGIVAL BLEEDING 9 0.0007
688 HEPATOCELLULAR CARCINOMA 5 0.0007
689 RASH GENERALISED 17 0.0007
690 PRESCRIBED UNDERDOSE 13 0.0007
691 OVARIAN CANCER 6 0.0007
692 GRAND MAL CONVULSION 6 0.0006
693 SPINAL FRACTURE 13 0.0006
694 CARDIO-RESPIRATORY ARREST 27 0.0006
695 APNOEA 5 0.0006
696 CHOLELITHIASIS 21 0.0006
697 GASTROINTESTINAL INFLAMMATION 5 0.0006
698 MALAISE 278 0.0006
699 DISORIENTATION 25 0.0006
700 DYSPEPSIA 62 0.0006
701 TRANSIENT ISCHAEMIC ATTACK 21 0.0006
702 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 112 0.0006
703 ANOREXIA 8 0.0006
704 LIVER FUNCTION TEST ABNORMAL 18 0.0006
705 NO ADVERSE EVENT 112 0.0006
706 RESPIRATORY ARREST 17 0.0006
707 LIMB DISCOMFORT 19 0.0006
708 PLATELET COUNT INCREASED 8 0.0006
709 DECUBITUS ULCER 5 0.0006
710 MYOCARDITIS 7 0.0006
711 FEELING COLD 17 0.0006
712 EATING DISORDER 13 0.0006
713 OSTEONECROSIS 20 0.0006
714 BEDRIDDEN 8 0.0006
715 OSTEOMYELITIS 11 0.0006
716 VASCULITIS 7 0.0006
717 HYPOAESTHESIA ORAL 9 0.0006
718 HAEMODIALYSIS 5 0.0006
719 CARDIOVASCULAR DISORDER 15 0.0006
720 NIGHT SWEATS 19 0.0006
721 RHINORRHOEA 38 0.0006
722 PRODUCT PRESCRIBING ERROR 14 0.0006
723 ABDOMINAL PAIN UPPER 121 0.0006
724 LYMPHOMA 9 0.0006
725 PROSTATIC SPECIFIC ANTIGEN INCREASED 8 0.0006
726 NOCTURIA 7 0.0006
727 SOMNOLENCE 116 0.0006
728 TENDERNESS 6 0.0006
729 NO THERAPEUTIC RESPONSE 7 0.0006
730 APHONIA 8 0.0006
731 SHOCK 13 0.0006
732 LYMPHADENOPATHY 20 0.0006
733 ORAL HERPES 11 0.0006
734 LIVER FUNCTION TEST INCREASED 12 0.0006
735 DRY MOUTH 45 0.0006
736 LUNG DISORDER 27 0.0006
737 LOWER RESPIRATORY TRACT INFECTION 25 0.0005
738 SKIN IRRITATION 25 0.0005
739 MUSCULAR WEAKNESS 62 0.0005
740 HEPATIC ENZYME INCREASED 37 0.0005
741 SKIN DISORDER 18 0.0005
742 LETHARGY 31 0.0005
743 APPENDICITIS 5 0.0005
744 RESPIRATORY DISORDER 16 0.0005
745 OFF LABEL USE 465 0.0005
746 HYPOAESTHESIA 79 0.0005
747 SWELLING FACE 34 0.0005
748 CONFUSIONAL STATE 84 0.0005
749 ORTHOSTATIC HYPOTENSION 9 0.0005
750 HYPOGLYCAEMIA 25 0.0005
751 LOSS OF CONSCIOUSNESS 66 0.0005
752 EXPOSURE DURING PREGNANCY 32 0.0005
753 HEART RATE INCREASED 51 0.0005
754 HEART RATE DECREASED 18 0.0005
755 UNDERDOSE 37 0.0005
756 INTESTINAL OBSTRUCTION 19 0.0005
757 CHOLECYSTITIS 6 0.0005
758 NECK PAIN 28 0.0005
759 DIPLOPIA 13 0.0005
760 SKIN DISCOLOURATION 23 0.0005
761 TOOTHACHE 9 0.0005
762 STEVENS-JOHNSON SYNDROME 11 0.0005
763 SEIZURE 57 0.0005
764 DIALYSIS 7 0.0005
765 SPINAL OPERATION 6 0.0005
766 SWOLLEN TONGUE 15 0.0005
767 BRONCHITIS 35 0.0005
768 WHEEZING 28 0.0005
769 RENAL DISORDER 22 0.0005
770 DIZZINESS 234 0.0005
771 CHOLESTASIS 9 0.0005
772 BLOOD PRESSURE INCREASED 71 0.0005
773 HIATUS HERNIA 6 0.0005
774 PULMONARY CONGESTION 6 0.0005
775 ADVERSE REACTION 6 0.0005
776 OSTEOARTHRITIS 19 0.0004
777 LIVER INJURY 11 0.0004
778 AGEUSIA 11 0.0004
779 DRUG TOXICITY 6 0.0004
780 ABSCESS 7 0.0004
781 SKIN EXFOLIATION 37 0.0004
782 SKIN LESION 12 0.0004
783 PRURITUS 168 0.0004
784 CONVULSION 25 0.0004
785 PERIPHERAL COLDNESS 6 0.0004
786 HERPES ZOSTER 25 0.0004
787 GASTRIC HAEMORRHAGE 5 0.0004
788 NEOPLASM MALIGNANT 29 0.0004
789 RHABDOMYOLYSIS 18 0.0004
790 CONJUNCTIVITIS 8 0.0004
791 PAIN IN EXTREMITY 127 0.0004
792 HEPATITIS 11 0.0004
793 MYALGIA 73 0.0004
794 VENTRICULAR TACHYCARDIA 7 0.0004
795 SEASONAL ALLERGY 6 0.0004
796 THERAPY NON-RESPONDER 19 0.0004
797 HEADACHE 265 0.0004
798 VIRAL INFECTION 14 0.0004
799 COMA 20 0.0004
800 SUBDURAL HAEMATOMA 6 0.0004
801 RECTAL HAEMORRHAGE 18 0.0004
802 URTICARIA 70 0.0004
803 HOSPITALISATION 64 0.0004
804 DEPRESSED MOOD 22 0.0004
805 HEPATITIS C 5 0.0004
806 FLUID OVERLOAD 6 0.0004
807 BLOOD PRESSURE SYSTOLIC INCREASED 8 0.0004
808 KIDNEY INFECTION 8 0.0004
809 ANGIOEDEMA 18 0.0004
810 GLOMERULAR FILTRATION RATE DECREASED 5 0.0004
811 FLATULENCE 23 0.0004
812 SKIN HAEMORRHAGE 6 0.0004
813 INTENTIONAL PRODUCT MISUSE 35 0.0004
814 OROPHARYNGEAL PAIN 37 0.0004
815 PRODUCT USE ISSUE 75 0.0004
816 PREMATURE BABY 12 0.0004
817 INSOMNIA 106 0.0004
818 PANCREATITIS 21 0.0004
819 OSTEOPENIA 6 0.0004
820 GOUT 7 0.0004
821 THYROID DISORDER 6 0.0004
822 SYNOVITIS 7 0.0004
823 GASTROENTERITIS VIRAL 7 0.0004
824 BURNING SENSATION 27 0.0004
825 HYPERSOMNIA 11 0.0004
826 THROAT IRRITATION 17 0.0004
827 BLOOD PRESSURE FLUCTUATION 9 0.0004
828 TREMOR 62 0.0004
829 TINNITUS 17 0.0004
830 LIMB INJURY 10 0.0004
831 AKATHISIA 5 0.0004
832 INTERVERTEBRAL DISC PROTRUSION 8 0.0004
833 IMPAIRED HEALING 12 0.0004
834 ABDOMINAL DISCOMFORT 61 0.0004
835 CORONARY ARTERY DISEASE 11 0.0004
836 SPEECH DISORDER 19 0.0004
837 TOOTH DISORDER 8 0.0004
838 DRY SKIN 48 0.0004
839 COORDINATION ABNORMAL 5 0.0004
840 HOT FLUSH 27 0.0004
841 FLUID RETENTION 18 0.0004
842 NERVOUS SYSTEM DISORDER 11 0.0004
843 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 9 0.0003
844 MUSCULOSKELETAL DISCOMFORT 6 0.0003
845 MUSCLE TWITCHING 8 0.0003
846 INJECTION SITE HAEMATOMA 5 0.0003
847 RASH MACULAR 12 0.0003
848 SYRINGE ISSUE 6 0.0003
849 LUNG NEOPLASM MALIGNANT 14 0.0003
850 NASAL CONGESTION 20 0.0003
851 RIB FRACTURE 7 0.0003
852 CONDITION AGGRAVATED 103 0.0003
853 URINARY INCONTINENCE 10 0.0003
854 THIRST 6 0.0003
855 COLORECTAL CANCER 16 0.0003
856 PALPITATIONS 39 0.0003
857 GAIT INABILITY 11 0.0003
858 DIABETES MELLITUS 25 0.0003
859 HIP ARTHROPLASTY 5 0.0003
860 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 17 0.0003
861 ECZEMA 17 0.0003
862 PROCEDURAL PAIN 9 0.0003
863 SURGERY 19 0.0003
864 CONTUSION 31 0.0003
865 HEPATIC CIRRHOSIS 6 0.0003
866 PAIN 195 0.0003
867 VISUAL IMPAIRMENT 39 0.0003
868 PULMONARY FIBROSIS 6 0.0003
869 GASTROINTESTINAL DISORDER 28 0.0003
870 BLISTER 17 0.0003
871 EPILEPSY 9 0.0003
872 DRUG ADMINISTRATION ERROR 9 0.0003
873 GAIT DISTURBANCE 56 0.0003
874 FEMUR FRACTURE 9 0.0003
875 TOXICITY TO VARIOUS AGENTS 49 0.0003
876 SWELLING 27 0.0003
877 POLLAKIURIA 12 0.0003
878 HAEMORRHAGE 30 0.0003
879 AGITATION 21 0.0003
880 GASTROOESOPHAGEAL REFLUX DISEASE 23 0.0003
881 INCORRECT DRUG ADMINISTRATION DURATION 8 0.0003
882 ABASIA 7 0.0003
883 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
884 DIABETES MELLITUS INADEQUATE CONTROL 5 0.0003
885 PRURITUS GENERALISED 6 0.0003
886 PANCREATIC CARCINOMA 8 0.0003
887 DEPRESSION 63 0.0003
888 INTENTIONAL PRODUCT USE ISSUE 24 0.0003
889 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 15 0.0003
890 PRODUCT QUALITY ISSUE 37 0.0003
891 DYSKINESIA 11 0.0003
892 SLEEP DISORDER 19 0.0003
893 MUSCLE SPASMS 49 0.0003
894 BLOOD URINE PRESENT 5 0.0003
895 FALL 87 0.0003
896 LOWER LIMB FRACTURE 5 0.0003
897 PAIN OF SKIN 7 0.0003
898 GLAUCOMA 5 0.0003
899 EAR PAIN 5 0.0003
900 HYPOACUSIS 11 0.0003
901 ARTHRITIS 20 0.0003
902 DISEASE RECURRENCE 12 0.0003
903 INFLAMMATION 13 0.0003
904 ANXIETY 71 0.0002
905 HIP FRACTURE 8 0.0002
906 COVID-19 43 0.0002
907 MEMORY IMPAIRMENT 33 0.0002
908 DYSSTASIA 7 0.0002
909 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 17 0.0002
910 HALLUCINATION 18 0.0002
911 NASOPHARYNGITIS 44 0.0002
912 GASTRIC CANCER 6 0.0002
913 HALLUCINATION, VISUAL 5 0.0002
914 MATERNAL EXPOSURE DURING PREGNANCY 21 0.0002
915 COGNITIVE DISORDER 11 0.0002
916 FEELING ABNORMAL 56 0.0002
917 ILLNESS 24 0.0002
918 BALANCE DISORDER 20 0.0002
919 MIGRAINE 22 0.0002
920 DISCOMFORT 14 0.0002
921 ANHEDONIA 6 0.0002
922 ARTHRALGIA 94 0.0002
923 OVERDOSE 48 0.0002
924 CEREBROVASCULAR ACCIDENT 37 0.0002
925 CATARACT 13 0.0002
926 MOVEMENT DISORDER 7 0.0002
927 PRODUCT DOSE OMISSION IN ERROR 6 0.0002
928 INTENTIONAL DOSE OMISSION 6 0.0002
929 WEIGHT INCREASED 47 0.0002
930 FOETAL EXPOSURE DURING PREGNANCY 17 0.0002
931 LOCALISED INFECTION 5 0.0002
932 INFLUENZA LIKE ILLNESS 17 0.0002
933 MENTAL IMPAIRMENT 5 0.0002
934 ADVERSE EVENT 19 0.0002
935 GASTRIC DISORDER 7 0.0002
936 LACRIMATION INCREASED 6 0.0002
937 DRUG INTOLERANCE 19 0.0002
938 PERIPHERAL SWELLING 30 0.0002
939 EMOTIONAL DISORDER 6 0.0002
940 OSTEOPOROSIS 8 0.0002
941 DRUG EFFECT INCOMPLETE 7 0.0002
942 EAR INFECTION 5 0.0002
943 LACTIC ACIDOSIS 6 0.0002
944 ACNE 14 0.0002
945 DRUG INEFFECTIVE 243 0.0002
946 EYE DISORDER 6 0.0002
947 MOBILITY DECREASED 13 0.0002
948 EXPIRED PRODUCT ADMINISTERED 6 0.0002
949 MEDICATION ERROR 10 0.0002
950 BREAST CANCER 16 0.0002
951 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 5 0.0002
952 VISION BLURRED 23 0.0002
953 DISTURBANCE IN ATTENTION 9 0.0002
954 EMOTIONAL DISTRESS 20 0.0002
955 ILL-DEFINED DISORDER 10 0.0002
956 EYE SWELLING 6 0.0002
957 BONE DENSITY DECREASED 5 0.0002
958 MUSCULOSKELETAL STIFFNESS 13 0.0001
959 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 5 0.0001
960 OCULAR HYPERAEMIA 7 0.0001
961 ADVERSE DRUG REACTION 13 0.0001
962 INFLUENZA 16 0.0001
963 MENTAL DISORDER 6 0.0001
964 MYOCARDIAL INFARCTION 24 0.0001
965 CARDIAC FAILURE CONGESTIVE 11 0.0001
966 SINUSITIS 14 0.0001
967 THERAPY CESSATION 7 0.0001
968 UNEVALUABLE EVENT 10 0.0001
969 THERAPEUTIC RESPONSE DECREASED 8 0.0001
970 BLOOD CHOLESTEROL INCREASED 6 0.0001
971 TREATMENT NONCOMPLIANCE 7 0.0001
972 EYE PAIN 7 0.0001
973 AMNESIA 8 0.0001
974 DRY EYE 6 0.0001
975 AGGRESSION 6 0.0001
976 PRODUCT DOSE OMISSION ISSUE 35 0.0001
977 CHRONIC KIDNEY DISEASE 9 0.0001
978 BLOOD GLUCOSE INCREASED 21 0.0001
979 CARDIAC DISORDER 10 0.0001
980 EYE IRRITATION 6 0.0001
981 IRRITABILITY 6 0.0001
982 INJURY 7 0.0001
983 PROSTATE CANCER 8 0.0001
984 INJECTION SITE ERYTHEMA 12 0.0001
985 DEPENDENCE 5 0.0001
986 ASTHMA 10 0.0001
987 INJECTION SITE HAEMORRHAGE 6 0.0001
988 INCORRECT DOSE ADMINISTERED 14 0.0001
989 PSORIASIS 8 0.0001
990 INJECTION SITE PAIN 15 0.0000
991 DRUG DOSE OMISSION 7 0.0000